Literature DB >> 26962126

Right Ventricular Volumes and Systolic Function by Cardiac Magnetic Resonance and the Impact of Sex, Age, and Obesity in a Longitudinally Followed Cohort Free of Pulmonary and Cardiovascular Disease: The Framingham Heart Study.

Murilo Foppa1, Garima Arora1, Philimon Gona, Arman Ashrafi, Carol J Salton, Susan B Yeon, Susan J Blease, Daniel Levy, Christopher J O'Donnell, Warren J Manning, Michael L Chuang.   

Abstract

BACKGROUND: Cardiac magnetic resonance is uniquely well suited for noninvasive imaging of the right ventricle. We sought to define normal cardiac magnetic resonance reference values and to identify the main determinants of right ventricular (RV) volumes and systolic function using a modern imaging sequence in a community-dwelling, longitudinally followed cohort free of clinical cardiovascular and pulmonary disease. METHODS AND
RESULTS: The Framingham Heart Study Offspring cohort has been followed since 1971. We scanned 1794 Offspring cohort members using steady-state free precession cardiac magnetic resonance and identified a reference group of 1336 adults (64±9 years, 576 men) free of prevalent cardiovascular and pulmonary disease. RV trabeculations and papillary muscles were considered cavity volume. Men had greater RV volumes and cardiac output before and after indexation to body size (all P<0.001). Women had higher RV ejection fraction than men (68±6% versus 64±7%; P<0.0001). RV volumes and cardiac output decreased with advancing age. There was an increase in raw and height-indexed RV measurements with increasing body mass index, but this trend was weakly inverted after indexation of RV volumes to body surface area. Sex, age, height, body mass index, and heart rate account for most of the variability in RV volumes and function in this community-dwelling population.
CONCLUSIONS: We report sex-specific normative values for RV measurements among principally middle-aged and older adults. RV ejection fraction is greater in women. RV volumes increase with body size, are greater in men, and are smaller in older people. Body surface area seems to be appropriate for indexation of cardiac magnetic resonance-derived RV volumes.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cardiac MRI; cardiac volume; epidemiology; right ventricle; systolic function

Mesh:

Year:  2016        PMID: 26962126     DOI: 10.1161/CIRCIMAGING.115.003810

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  22 in total

Review 1.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.

Authors:  Martin A Alpert; Jad Omran; Brian P Bostick
Journal:  Curr Obes Rep       Date:  2016-12

3.  Left and right ventricular parameters corrected with threshold-based quantification method in a normal cohort analyzed by three independent observers with various training-degree.

Authors:  Ibolya Csecs; Csilla Czimbalmos; Ferenc Imre Suhai; Róbert Mikle; Arash Mirzahosseini; Zsófia Dohy; Andrea Szűcs; Anna Réka Kiss; Tamás Simor; Attila Tóth; Béla Merkely; Hajnalka Vágó
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-28       Impact factor: 2.357

4.  The prognostic significance of early and late right precordial lead (V4 R) ST-segment elevation in patients with acute anterior myocardial infarction.

Authors:  Muhammed Keskin; Ahmet Okan Uzun; Edibe Betül Börklü; Mert İlker Hayıroğlu; Ceyhan Türkkan; Ahmet İlker Tekkeşin; Ömer Kozan
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-10-14       Impact factor: 1.468

Review 5.  Pulmonary Arterial Hypertension and the Sex Hormone Paradox.

Authors:  Andrew Foderaro; Corey E Ventetuolo
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

6.  Correlation between right ventricular T1 mapping and right ventricular dysfunction in non-ischemic cardiomyopathy.

Authors:  Christine L Jellis; Teerapat Yingchoncharoen; Neville Gai; Kenya Kusunose; Zoran B Popović; Scott Flamm; Deborah Kwon
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-29       Impact factor: 2.357

7.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

Review 8.  70-year legacy of the Framingham Heart Study.

Authors:  Charlotte Andersson; Andrew D Johnson; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2019-11       Impact factor: 32.419

9.  Sex differences in right ventricular adaptation to pressure overload in a rat model.

Authors:  Tik-Chee Cheng; Diana M Tabima; Laura R Caggiano; Andrea L Frump; Timothy A Hacker; Jens C Eickhoff; Tim Lahm; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2022-02-03

Review 10.  Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.

Authors:  Jane A Leopold; Steven M Kawut; Micheala A Aldred; Stephen L Archer; Ray L Benza; Michael R Bristow; Evan L Brittain; Naomi Chesler; Frances S DeMan; Serpil C Erzurum; Mark T Gladwin; Paul M Hassoun; Anna R Hemnes; Tim Lahm; Joao A C Lima; Joseph Loscalzo; Bradley A Maron; Laura Mercer Rosa; John H Newman; Susan Redline; Stuart Rich; Franz Rischard; Lissa Sugeng; W H Wilson Tang; Ryan J Tedford; Emily J Tsai; Corey E Ventetuolo; YouYang Zhou; Neil R Aggarwal; Lei Xiao
Journal:  Circ Heart Fail       Date:  2021-06-15       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.